Zivo Bioscience, Inc.
ZIVOOTCCIK 1101026HealthcareFiscal year ends Dec 31
Reports and events: 264 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-03-3008:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-002928 |
| 2026-02-2720:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-021894 |
| 2025-12-2316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-25-014296 |
| 2025-11-1416:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001654954-25-013095 |
| 2025-09-1009:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-010579 |
| 2025-08-1816:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-25-009772 |
| 2025-08-1416:21 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001654954-25-009650 |
| 2025-07-1416:59 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-25-008035 |
| 2025-06-1116:10 ET | 8-K | 5.07 Shareholder vote results | 0001654954-25-006837 |
| 2025-05-1516:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001654954-25-005748 |
| 2025-04-2516:36 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001654954-25-004654 |
| 2025-03-1816:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001654954-25-002948 |
| 2025-01-2717:21 ET | 8-K | 3.02 Unregistered sale of equity | 0001654954-25-000805 |
| 2025-01-1517:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-25-000453 |
| 2025-01-0716:05 ET | 8-K | 8.01 Other events | 0001654954-25-000173 |
| 2024-11-1506:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-24-014503 |
| 2024-11-1416:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001654954-24-014463 |
| 2024-10-1817:26 ET | 8-K | 3.02 Unregistered sale of equity | 0001654954-24-013107 |
| 2024-10-0114:57 ET | SC 13D/A | Ownership report, active investor, amended | 0001618035-24-000005 |
| 2024-08-1416:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001654954-24-010644 |
| 2024-07-1716:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-24-009069 |
| 2024-06-1316:47 ET | 8-K | 5.07 Shareholder vote results | 0001654954-24-007730 |
| 2024-06-1220:49 ET | SC 13D | Ownership report, active investor | 0001654954-24-007677 |
| 2024-06-1220:44 ET | SC 13D | Ownership report, active investor | 0001654954-24-007676 |
| 2024-06-1220:36 ET | SC 13D | Ownership report, active investor | 0001654954-24-007675 |
| 2024-06-0721:22 ET | SC 13D/A | Ownership report, active investor, amended | 0001654954-24-007537 |
| 2024-06-0706:02 ET | 8-K/A | 1.01 Entry into a material agreement | 0001654954-24-007479 |
| 2024-06-0616:54 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-007455 |
| 2024-05-1316:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001654954-24-006082 |
| 2024-04-2608:00 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001654954-24-005060 |
| 2024-04-0911:49 ET | SC 13D/A | Ownership report, active investor, amended | 0001174947-24-000523 |
| 2024-03-1516:43 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001654954-24-003228 |
| 2024-03-1409:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001618035-24-000004 |
| 2024-02-1516:45 ET | 8-K | 3.01 Delisting notice | 0001654954-24-001856 |
| 2024-01-2217:15 ET | SC 13D | Ownership report, active investor | 0001654954-24-000795 |
| 2024-01-1716:11 ET | 8-K | 3.02 Unregistered sale of equity | 0001654954-24-000694 |
| 2024-01-0517:17 ET | 8-K | 3.02 Unregistered sale of equity | 0001654954-24-000274 |
| 2024-01-0317:23 ET | 8-K | 3.02 Unregistered sale of equity | 0001654954-24-000154 |
| 2023-12-1116:42 ET | 8-K | 3.02 Unregistered sale of equity | 0001654954-23-015370 |
| 2023-11-2709:29 ET | 8-K | 3.01 Delisting notice | 0001654954-23-014775 |
| 2023-11-2216:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-23-014712 |
| 2023-11-1316:18 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001654954-23-014165 |
| 2023-11-0310:18 ET | S-1/A | Registration statement, amended | 0001654954-23-013753 |
| 2023-11-0118:20 ET | S-1/A | Registration statement, amended | 0001654954-23-013618 |
| 2023-10-3013:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001174947-23-001251 |
| 2023-10-2608:56 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-23-013408 |
| 2023-10-0417:08 ET | S-1 | Registration statement | 0001654954-23-012588 |
| 2023-08-1416:17 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001654954-23-010769 |
| 2023-08-0916:17 ET | 8-K | 3.01 Delisting notice | 0001654954-23-010378 |
| 2023-07-0616:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001654954-23-008880 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.